Kala Pharmaceuticals Statistics

Total Valuation

KALA has a market cap or net worth of $19.04 million. The enterprise value is $7.12 million.

Market Cap	19.04M
Enterprise Value	7.12M

Important Dates

The next estimated earnings date is Friday, August 2, 2024, before market open.

Earnings Date	Aug 2, 2024
Ex-Dividend Date	n/a

Share Statistics

KALA has 2.82 million shares outstanding. The number of shares has increased by 35.96% in one year.

Shares Outstanding	2.82M
Shares Change (YoY)	+35.96%
Shares Change (QoQ)	+3.60%
Owned by Insiders (%)	5.43%
Owned by Institutions (%)	40.27%
Float	1.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.86
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 5.49.

Current Ratio	4.22
Quick Ratio	n/a
Debt / Equity	5.49
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.83

Financial Efficiency

Return on equity (ROE) is -368.90% and return on invested capital (ROIC) is -94.53%.

Return on Equity (ROE)	-368.90%
Return on Assets (ROA)	-66.90%
Return on Capital (ROIC)	-94.53%
Revenue Per Employee	n/a
Profits Per Employee	-$919,791
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.28% in the last 52 weeks. The beta is -2.04, so KALA's price volatility has been lower than the market average.

Beta (5Y)	-2.04
52-Week Price Change	-53.28%
50-Day Moving Average	6.53
200-Day Moving Average	7.03
Relative Strength Index (RSI)	49.66
Average Volume (20 Days)	706,192

Short Selling Information

The latest short interest is 295,184, so 10.48% of the outstanding shares have been sold short.

Short Interest	295,184
Short Previous Month	13,520
Short % of Shares Out	10.48%
Short % of Float	15.19%
Short Ratio (days to cover)	0.51

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.86M
Pretax Income	-39.55M
Net Income	-39.55M
EBITDA	-33.22M
EBIT	-33.76M
Earnings Per Share (EPS)	-$14.96

Full Income Statement

Balance Sheet

The company has $48.48 million in cash and $36.56 million in debt, giving a net cash position of $11.92 million or $4.23 per share.

Cash & Cash Equivalents	48.48M
Total Debt	36.56M
Net Cash	11.92M
Net Cash Per Share	$4.23
Equity (Book Value)	6.66M
Book Value Per Share	2.37
Working Capital	38.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.09 million and capital expenditures -$468,000, giving a free cash flow of -$29.56 million.

Operating Cash Flow	-29.09M
Capital Expenditures	-468,000
Free Cash Flow	-29.56M
FCF Per Share	-$10.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.96%
Shareholder Yield	-35.96%
Earnings Yield	-207.73%
FCF Yield	-155.23%

Analyst Forecast

The average price target for KALA is $16.50, which is 144.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.50
Price Target Difference	144.08%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	1:50

Scores

Altman Z-Score	n/a
Piotroski F-Score	2